functional improvement dystrophic muscle myostatin blockade
mice cattle mutations myostatin gdf8 gene show marked increase body weight muscle mass indicating new member tgf-beta superfamily negative regulator skeletal muscle growth inhibition myostatin gene product predicted increase muscle mass improve disease phenotype variety primary secondary myopathies tested ability inhibition myostatin vivo ameliorate dystrophic phenotype mdx mouse model duchenne muscular dystrophy dmd- blockade endogenous myostatin using intraperitoneal injections blocking antibodies three months resulted increase body weight muscle mass muscle size absolute muscle strength mdx mouse muscle along significant decrease muscle degeneration concentrations serum creatine kinase functional improvement dystrophic muscle myostatin blockade provides novel pharmacological strategy treatment diseases associated muscle wasting dmd circumvents major problems associated conventional gene therapy disorders
